GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Ultralife Corp (NAS:ULBI) » Definitions » Debt-to-Equity

Ultralife (Ultralife) Debt-to-Equity : 0.20 (As of Dec. 2023)


View and export this data going back to 1992. Start your Free Trial

What is Ultralife Debt-to-Equity?

Ultralife's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $2.0 Mil. Ultralife's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $23.6 Mil. Ultralife's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $125.3 Mil. Ultralife's debt to equity for the quarter that ended in Dec. 2023 was 0.20.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Ultralife's Debt-to-Equity or its related term are showing as below:

ULBI' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01   Med: 0.18   Max: 0.2
Current: 0.2

During the past 13 years, the highest Debt-to-Equity Ratio of Ultralife was 0.20. The lowest was 0.01. And the median was 0.18.

ULBI's Debt-to-Equity is ranked better than
60.6% of 2619 companies
in the Industrial Products industry
Industry Median: 0.28 vs ULBI: 0.20

Ultralife Debt-to-Equity Historical Data

The historical data trend for Ultralife's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ultralife Debt-to-Equity Chart

Ultralife Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.01 0.18 0.18 0.20

Ultralife Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.20 0.21 0.22 0.20

Competitive Comparison of Ultralife's Debt-to-Equity

For the Electrical Equipment & Parts subindustry, Ultralife's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ultralife's Debt-to-Equity Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Ultralife's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Ultralife's Debt-to-Equity falls into.



Ultralife Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Ultralife's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Ultralife's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ultralife  (NAS:ULBI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Ultralife Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Ultralife's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Ultralife (Ultralife) Business Description

Traded in Other Exchanges
Address
2000 Technology Parkway, Newark, NY, USA, 14513
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company design, manufacture, install and maintain power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from Battery and Energy Products segment.
Executives
Bradford T Whitmore 10 percent owner 5215 OLD ORCHARD ROAD, SUITE 620, SKOKIE IL 60077
Michael Edward Manna director, officer: President and CEO 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
W. Shaw Robert director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Janie Goddard director C/O ACON - 1133 CONNECTICUT AVENUE, NW, SUITE 700, WASHINGTON DC 20036
Thomas Louis Saeli director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Philip A Fain officer: Vice President C/O CXO ON THE GO OF DELAWARE, LLC, 3349 MONROE AVENUE, # 256, ROCHESTER NY 14618
Michael D Popielec director, officer: President and CEO 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Steven Mark Anderson director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Sunray I, Llc 10 percent owner 1560 SHERMAN AVENUE, SUITE 900, EVANSTON IL 60201
James A. Croce director 2000 TECHNOLOGY PARKWAY, NEWARK NY 14513
Spurgeon Corp 10 percent owner 407 S. THIRD STREET, SUITE 230, GENEVA IL 60134
Patricia C Barron director 6601 WEST BROAD STREET, P O BOX 27003, RICHMOND VA 23261-7003
Daniel W Christman director C/O ENTEGRIS, INC., 129 CONCORD ROAD, BILLERICA MA 01821
Paula H Cholmondeley director 221 W PHILADELPHIA ST, SUITE 60W, YORK PA 17401-2991
Ranjit C Singh director

Ultralife (Ultralife) Headlines